Your browser doesn't support javascript.
loading
Functional hypoxia drives neuroplasticity and neurogenesis via brain erythropoietin.
Wakhloo, Debia; Scharkowski, Franziska; Curto, Yasmina; Javed Butt, Umer; Bansal, Vikas; Steixner-Kumar, Agnes A; Wüstefeld, Liane; Rajput, Ashish; Arinrad, Sahab; Zillmann, Matthias R; Seelbach, Anna; Hassouna, Imam; Schneider, Katharina; Qadir Ibrahim, Abdul; Werner, Hauke B; Martens, Henrik; Miskowiak, Kamilla; Wojcik, Sonja M; Bonn, Stefan; Nacher, Juan; Nave, Klaus-Armin; Ehrenreich, Hannelore.
Afiliación
  • Wakhloo D; Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Göttingen, Germany.
  • Scharkowski F; Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Göttingen, Germany.
  • Curto Y; Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Göttingen, Germany.
  • Javed Butt U; Neurobiology Unit, Program in Neurosciences and Interdisciplinary Research Structure for Biotechnology and Biomedicine (BIOTECMED), Universitat de València, Burjassot, Spain.
  • Bansal V; Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Göttingen, Germany.
  • Steixner-Kumar AA; Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Göttingen, Germany.
  • Wüstefeld L; Institute of Medical Systems Biology, Center for Molecular Neurobiology, University Clinic Hamburg-Eppendorf, Hamburg, Germany.
  • Rajput A; Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Göttingen, Germany.
  • Arinrad S; Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Göttingen, Germany.
  • Zillmann MR; Institute of Medical Systems Biology, Center for Molecular Neurobiology, University Clinic Hamburg-Eppendorf, Hamburg, Germany.
  • Seelbach A; Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Göttingen, Germany.
  • Hassouna I; Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Göttingen, Germany.
  • Schneider K; Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Göttingen, Germany.
  • Qadir Ibrahim A; Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Göttingen, Germany.
  • Werner HB; Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Göttingen, Germany.
  • Martens H; Institute of Medical Systems Biology, Center for Molecular Neurobiology, University Clinic Hamburg-Eppendorf, Hamburg, Germany.
  • Miskowiak K; Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany.
  • Wojcik SM; Synaptic Systems GmbH, Göttingen, Germany.
  • Bonn S; Copenhagen Affective Disorder Research Centre, Psychiatric Centre Copenhagen, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Nacher J; Department of Molecular Neurobiology, Max Planck Institute of Experimental Medicine, Göttingen, Germany.
  • Nave KA; Institute of Medical Systems Biology, Center for Molecular Neurobiology, University Clinic Hamburg-Eppendorf, Hamburg, Germany.
  • Ehrenreich H; DFG Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB), Göttingen, Germany.
Nat Commun ; 11(1): 1313, 2020 03 09.
Article en En | MEDLINE | ID: mdl-32152318
ABSTRACT
Erythropoietin (EPO), named after its role in hematopoiesis, is also expressed in mammalian brain. In clinical settings, recombinant EPO treatment has revealed a remarkable improvement of cognition, but underlying mechanisms have remained obscure. Here, we show with a novel line of reporter mice that cognitive challenge induces local/endogenous hypoxia in hippocampal pyramidal neurons, hence enhancing expression of EPO and EPO receptor (EPOR). High-dose EPO administration, amplifying auto/paracrine EPO/EPOR signaling, prompts the emergence of new CA1 neurons and enhanced dendritic spine densities. Single-cell sequencing reveals rapid increase in newly differentiating neurons. Importantly, improved performance on complex running wheels after EPO is imitated by exposure to mild exogenous/inspiratory hypoxia. All these effects depend on neuronal expression of the Epor gene. This suggests a model of neuroplasticity in form of a fundamental regulatory circle, in which neuronal networks-challenged by cognitive tasks-drift into transient hypoxia, thereby triggering neuronal EPO/EPOR expression.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Encéfalo / Eritropoyetina / Neurogénesis / Hipoxia / Plasticidad Neuronal Límite: Animals / Female / Humans / Male Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2020 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Encéfalo / Eritropoyetina / Neurogénesis / Hipoxia / Plasticidad Neuronal Límite: Animals / Female / Humans / Male Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2020 Tipo del documento: Article País de afiliación: Alemania